The case for focused research organisations
Focused research organisations are moving “from concept to reality,” according to a new Innovation and Research Caucus report authored by the University of Glasgow’s Gemma Milne – and represent what is possible when the quest for institutional diversity is “acted upon rather than merely theorised.”
If you’ve not come across the term before, a focused research organisation (or FRO) is:
“a novel organisational form designed to fill a gap in mission-driven, product-based technology development that large university research labs, corporate R&D teams and deep tech startups are not well placed to undertake.”
This new type of research organisation, typically set up as a non-profit, pursues certain prespecified technical milestones across a fixed period, seeking to generate some missing resource which is acting as a bottleneck to scientific progress: a dataset or a method, for example. This resource should then be released as a public good upon completion, in order for others to build on it.
The approach requires a “dedicated, multidisciplinary team over several years” – a requirement which, supporters contend, does not suit the incentives of the academic grant cycle, corporate R&D budget terms, or a venture-backed business models.
The author argues strongly in favour with further experimentation with the FRO model, backed by government funding and other reforms to the research system which are currently acting as blockers. Such organisations are a “live experiment”, the report concludes, which respond to the question of what a resilient research and innovation ecosystem needs to sustain and increase its ambition – especially at a time when the UK higher education institutions which have traditionally performed much of the country’s research are struggling with a funding model that largely no longer works.
In context
This report for the Innovation and Research Caucus (IRC) was conducted in partnership with Convergent Research – the main organisation supporting focused research organisations in the UK and elsewhere – which was a named partner on the ESRC grant and was paid for its staff time. Findings are based on interviews with those involved in the landscape, either within FROs or in the wider research system.
The author identifies three focused research organisations currently operating in the UK. The first is Bind Research, which concentrates on mapping drug-binding capacities for disordered proteins. It was funded through the Department for Science, Innovation and Technology’s Research Ventures Catalyst opportunity to the tune of £12.9m, matched by co-investment from philanthropy; as the report explores in fascinating depth, setting up a suitable funding vehicle took a lot of cross-government negotiation.
DSIT’s funding programme was launched in summer 2023 with an eye to the Nurse review’s call for more institutional diversity. It was designed to support the establishment of “new organisational models to tackle a research challenge across any discipline.” In addition to Bind Research, it also funded PharosAI, which was built on a consortium of NHS trusts and other established institutions, and MEMetic, led by a team at Aston University. As Milne notes, there has been no news of any successor programme to the Research Ventures Catalyst.
The other two UK FROs are Meridial and Echo Labs, launched by Convergent Research and ARIA earlier this year. ARIA described its thinking thus:
“Some problems, such as large-scale infrastructure building and tool creation, don’t fit neatly into the major models of R&D. They can be too applied for academia, too field-wide in scope for industry, or too complex for fragmented funding.”
Convergent Research, which describes itself as a “mission control for frontier technology”, had already launched ten FROs in the USA. These ten organisations plus the three in the UK, the report notes, represent the extent of the focused research organisation landscape currently – but “much more evidence will be coming online soon.”
This is because the US National Science Foundation has announced $1.5bn in funding over a decade for what it has termed X-Labs, following the focused research organisation model, with a first round targeted at quantum and computational imaging. The Trump administration’s Science: A Golden Age policy paper was supportive of the FRO approach, saying that they would act as a spur for ideas that “researchers have rarely dared to pursue thus far because there are no avenues for them,” and would allow federal bodies to “bypass traditional grant constraints.”
In the context of the National Science Foundation’s science board having its members dismissed in early 2026, alongside other moves to allow political appointees to make research funding decisions, the X-Labs initiative has provoked no small concern in the USA – though the IRC report observes that certain American universities are currently seeking to work out “how they might spin up an X-Lab within their own administration.”
What works
The report finds that FROs have borrowed various elements of the start-up operating model, despite generally being non-for-profit organisations. This can be seen in staffing structures, with a chief executive in charge and the ability to recruit flexibly, and is also reflected in remuneration:
“By registering as private organisations, FROs have the added advantage of being able to set pay at levels that pull together competitive teams (in comparison to the standardised pay grades applied in UK academia), which can help incentivise career moves away from both industrial research jobs and the traditional prestige and job security of academia.”
The report’s author goes on to suggest that the FRO model has the potential to generate “impactful shifts in the UK research workforce”, due not only to pay but also in the organisations’ ability to cater for a dynamic and ambitious working approach. Milne finds evidence that researchers are already moving both into and out of FROs, which she presents as evidence that the traditional fear over “gaps in the CV” is not precluding researchers from using FROs as part of a broader academic journey:
“If the FRO offers something that a particular strand of research talent cannot get elsewhere, then the UK’s offer to that talent – time-limited roles, competitive pay, and a route back into academia without penalty – is part of how resilient and attractive the research workforce is. Universities and funders should consider how these pathways connect.”
The wider question of how FROs fit into the UK’s university-predominant research landscape is another area where the report makes recommendations. Those working in these organisations are said to have “universally acknowledged” the value of universities – but equally feel a “deep frustration” at not being able to engage with them more, for various reasons said to include culture and bureaucracy. There were calls for universities to “join the FRO movement,” including by way of offering talent, equipment and reach.
The other significant policy recommendation is for UKRI to amend its eligibility rules, which are said to be regularly acting as a barrier for this kind of small, novel organisations. One of the FROs, Echo Labs, is said to have explored whether it could access the UKRI Future Leaders Fellows scheme, only to find the rules “too unclear,” given that FROs are not universities or research institutes, nor set up as conventional businesses.
The same tension was highlighted over the summer in an open letter to UKRI coordinated by the Science Works think tank, which suggested that the current state of affairs amounts to a “de facto ban” on new research organisations. Milne says that she has added her name to the letter as a signatory based on the findings of her research.
Future scope
Whether there is movement on eligibility, or future government initiatives in this space in the mould of the Research Ventures Catalyst, this report makes a sustained case for further action. It concludes that focused research organisations are a “key contemporary example of what effervesces through the ecosystem when institutional diversity is acted upon rather than merely theorised.”
Milne argues that – given the growing emphasis on metascience, and the many still-unresolved issues raised by the Nurse review of the research landscape – further discussion about how to support and incentivise new FROs is especially timely:
“If now is not the right moment to think deeply and deliberately about these tensions, to experiment with new models and approaches in the public realm, to take calculated risks and place bets on portfolios of different kinds of expertise, and to go beyond incremental, descriptive and backward-looking modes of metascience towards inventive, imaginative and critically active interventionist forms – I’m not sure when is.”